Table 1 Characteristic of the survey population by group
| Â | Group A | Group B |
|---|---|---|
N (Men/Women) | 57 (43/14) | 59 (39/20) |
Age (yr.) | 69 (58–74) | 70 (57–76) |
Duration of disease (yr) | 19 (10–26) | 19 (10–28) |
Diabetes complications n (%) | Â | Â |
Diabetic retinopathy | 35 (61) | 33 (56) |
Diabetic neuropathy | 44 (77) | 47 (80) |
Diabetic nephropathy | 26 (46) | 33 (56) |
Diabetes Treatment n (%) | Â | Â |
Oral agents | 18 (32) | 20 (34) |
Insulin | 41 (72) | 37 (63) |
Lipid lowering Treatment n (%) | Â | Â |
Statins | 44 (77) | 35 (59) |
Fibrates | 2 (4) | 7 (12) |
Antihypertensive treatment n (%) | Â | Â |
ACE inhibitors or ARA II | 51 (88) | 46 (78) |
3 or more drugs | 7 (12) | 11 (19) |
Antiaggregation n (%) | 50 (88) | 53 (90) |
Actual smokers n (%) | 11 (19) | 11 (19) |
Inclusion criteria n (%) | Â | Â |
Arterial reconstruction | 27 (47) | 30 (51) |
Foot ulcer | 16 (28) | 12 (20) |
ABI < 0.8 | 14 (25) | 17 (29) |